Signature Healthcare Of Muncie
SIGNATURE HEALTHCARE OF MUNCIE in MUNCIE, IN — inspection on October 24, 2025.
Found 2 citations. Severity: Standard violations.
Health inspections identify deficiencies that facilities must correct within required timeframes. Violations range from minor documentation issues to serious safety concerns and are subject to follow-up verification.
Inspection Findings
injuries of unknown origin. and to assure that all alleged violations of federal or State laws which involve abuse, neglect, exploitation, injuries of unknown origin and misappropriation of resident property are. reported immediately to the Facility Administrator, the State Survey Agency, and other appropriate State and local agencies in accordance with Federal and State law.
The Facility Administrator is responsible for reporting all investigations' results to applicable State agencies as required by Federal and State law.
Immediately.
All alleged violations involving abuse, Neglect, exploitation, or mistreatment are reported immediately, but no later than two hours after the allegation is made. In other words, all allegations and incidents of abuse or neglect, as defined in this policy, will be reported immediately, as defined in this paragraph.
Cross reference F-F610 This citation relates to Intakes 2634309 and 2641871. 3.1-28(c)
Facility ID:
IDENTIFICATION NUMBER:
A.
Building
COMPLETED
10/24/2025
STREET ADDRESS, CITY, STATE, ZIP CODE
Signature Healthcare of Muncie
4301 N Walnut St Muncie, IN 47303
SUMMARY STATEMENT OF DEFICIENCIES
not remember if she had spoken to Resident C, and she could not recall if she went to Resident B and Resident C's room that day.
On 10/24/25 at 4:03 p.m., the DON indicated she was aware of the previous medication error that occurred on 8/25/25, when Resident B received Resident C's medications, as the DON had assisted in the facility's investigation.
She was notified on 9/25/25 around 9:00 a.m. that Resident B did not eat well, and they were going to send the resident out for shortness of breath.
The DON and Administrator had completed the facility investigation for 9/25/25.
The hospital Case Manager contacted the DON on 9/25/25, asked about the medication list, and notified her the resident tested positive for opiates on the drug screen.
Resident B did not have orders for opiates and the DON was aware.
She did not communicate with the hospital that Resident B had previously received Resident C's medication on 8/25/25.
Resident C could have answered yes/no questions, but she could not state her name and date of birth .
Resident C's cognition was impaired, so a statement was not taken from her.
They did not have staff statements because they did not find anything on their end.
On 10/24/25 at 4:54 p.m., the Administrator indicated she had not collected any statements because the DON talked to the nursing staff.
The facility could not confirm who had been spoken with since no statements were collected. No further information was provided.
The article, Morphine, dated 3/27/25, was retrieved on 11/14/25 at 10:03 a.m. from the National Institute of Health (NIH) website https://www.ncbi.nlm.nih.gov/books/NBK526115/#article-25271.s8.
The guidance included : According to the Centers for Disease Control Prevention (CDC) guidelines, clinicians should not use extended-release/long-acting opioids, including morphine, to treat acute pain or initiate opioid treatment for subacute or chronic pain.
Due to their longer half life and duration of effects, such as respiratory depression, ER/LA opioids should be reserved for severe continuous pain.
Toxicity.
Signs and Symptoms of Overdose.
Morphine can potentially be a lethal medication when not used properly.
This medication causes a host of symptoms related to CNS depression.
Severe respiratory depression is the most feared complication of morphine in cases of overdose.
Acute morphine overdose can be present with a variety of symptoms, including respiratory depression, skeletal muscle flaccidity, cold and clammy skin, hypoglycemia, bradycardia, hypotension, constricted pupils, pulmonary edema, somnolence progressing to coma, partial or complete airway obstruction.
The article, Extended-release morphine sulfate in treatment of severe acute and chronic pain, dated 9/21/10, was retrieved on 11/17/25 from the NIH website at https://pmc.ncbi.nlm.nih.gov/articles/PMC3004644/.
The guidance included: Pharmacodynamics. It takes approximately 30 minutes for the immediate-release morphine formulation to reach the central nervous system, and 90 minutes for the extended-release formulation.
A current facility policy, last reviewed 1/31/25, titled Abuse, Neglect and Misappropriation of Property, provided by the Administrator on 10/22/25 at 11:30 a.m., indicated the following: POLICY STATEMENT.It is the organization's intention to prevent the occurrence of abuse, neglect, exploitation, injuries of unknown origin. and to assure that all alleged violations of federal or State laws which involve abuse, neglect, exploitation, injuries of unknown origin and misappropriation of resident property are investigated.
The organization's policy is that the Facility Administrator, or his or her designee, will conduct a reasonable investigation of each such alleged violation.
This citation relates to Intakes 2634309 and 2641871. 3.1-28(d)
Facility ID: